CGRP receptor
Assets acting on this target.
- Class
- CGRP receptor antagonist
- Notes
- mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT04346615 names the target); source: https://clinicaltrials.gov/study/NCT04346615
By indication
Related mechanisms
CGRP receptor drugs compared
5 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Atogepant (Qulipta)Qulipta | AbbVie | small molecule | Approved | Approved in Migraine |
| Erenumab (Aimovig)Aimovig | Amgen, Novartis | monoclonal antibody | Approved | Approved in Migraine |
| Rimegepant (Nurtec ODT)Nurtec ODT | Eisai, Pfizer | small molecule | Approved | Approved in Migraine |
| Ubrogepant (Ubrelvy)Ubrelvy | AbbVie | small molecule | Approved | Approved in Migraine |
| Zavegepant (Zavzpret)Zavzpret | Pfizer | small molecule | Approved | Approved in Migraine |